CHOLESTYRAMINE LIGHT POWDER
For 1 g
Pharmacies pay
$0.11 – $0.28 filed
1 × $0.11311 to $0.28353 per GM (the 7 NDCs differ)
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2025-11-19, 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$1.11 filed
1 × $1.10594 per GM, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
9.8× estimated
Medicare paid 9.8× what pharmacies pay.
Part D averages every strength and form sold under “Cholestyramine Light” / “Cholestyramine” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$5.13 – $5.32 estimated
NADAC for the pack + 15% + $5.00 fee per fill
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
CHOLESTYRAMINE LIGHT POWDER is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “cholestyramine”, “cholestyramine for oral suspension” and “cholestyramine light”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as “powder, for suspension” and “powder” and its route as oral.
FDA lists 6 labelers (the companies named on the label) for its NDCs, among them PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS, EPIC PHARMA, LLC and Par Health USA, LLC.
FDA’s Established Pharmacologic Class for it is Bile Acid Sequestrant.
The NADAC file of 2026-10-14 prices it under 7 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $0.11 – $0.28 for 1 g, depending on the NDC ($0.11311 to $0.28353 per GM), by the CMS NADAC file of 2026-10-14; those prices took effect between 2025-11-19 and 2026-09-30. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 4, carried forward from the previous file; 5, calculated based on package size.
The NADAC of 1 of these 7 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: it took effect on 2025-11-19. The file is new; the price is not.
What NADAC measures · NADAC explanation codes · Carried-forward prices
The 6 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 2 | $0.11311 per GM filed |
| Chartwell RX, LLC | 1 | $0.11311 per GM filed |
| EPIC PHARMA, LLC | 1 | $0.11311 per GM filed |
| Par Health USA, LLC | 1 | $0.28353 per GM filed |
| Precision Dose, Inc. | 1 | $0.14543 per GM filed |
| Zydus Pharmaceuticals (USA) Inc. | 1 | $0.16976 per GM filed |
When these prices took effect
- 2026-09-30 · 1 NDC · $0.11311 per GM filed
- 2026-09-23 · 5 NDCs · $0.11311 to $0.28353 per GM filed
- 2025-11-19 · 1 NDC, carried forward from an earlier file · $0.14543 per GM filed
All 7 NDCs, with labeler and price
- 24658-0271-93 · PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS · $0.11311 per GM · eff. 2026-09-30 filed
- 24658-0271-97 · PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS · $0.11311 per GM · eff. 2026-09-23 filed
- 42806-0271-93 · EPIC PHARMA, LLC · $0.11311 per GM · eff. 2026-09-23 filed
- 49884-0466-67 · Par Health USA, LLC · $0.28353 per GM · eff. 2026-09-23 filed
- 62135-0937-54 · Chartwell RX, LLC · $0.11311 per GM · eff. 2026-09-23 filed
- 68094-0906-10 · Precision Dose, Inc. · $0.14543 per GM · eff. 2025-11-19 filed carried forward
- 68382-0529-42 · Zydus Pharmaceuticals (USA) Inc. · $0.16976 per GM · eff. 2026-09-23 filed
Other strengths, forms and brands
5 other products in the NADAC file share an FDA nonproprietary name with CHOLESTYRAMINE LIGHT POWDER.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| CHOLESTYRAMINE LIGHT PACKET | $0.83267 per EA filed | We don’t know yet |
| CHOLESTYRAMINE LIGHT POWDER this page | $0.11311 to $0.28353 per GM filed | $1.10594 per GM filed |
| CHOLESTYRAMINE PACKET | $0.83426 per EA filed | We don’t know yet |
| CHOLESTYRAMINE POWDER | $0.08508 to $0.0924 per GM filed | We don’t know yet |
| PREVALITE PACKET | $0.83267 per EA filed | We don’t know yet |
| PREVALITE POWDER | $0.16976 per GM filed | We don’t know yet |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2025-11-19, 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 7 NDCs’ NADAC prices is $0.11311 per GM filed.
Of the 3 other products in FDA’s Bile Acid Sequestrant class priced per GM, 2 have a higher middle NADAC price and 1 a lower one. The one in the middle is PREVALITE POWDER, at $0.16976 per GM filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $1.11 for 1 g, at an average of $1.10594 per GM in 2024 (2024-01-01 to 2024-12-31) for “Cholestyramine Light” and “Cholestyramine”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 155,684 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
1 of the product’s 7 NDCs have this Medicare figure; the other 6 do not, and the interactive card says why for each.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 1 g? Is it lower than what I would pay through my insurance?
- Which NDC (the 11-digit number on the package) is this? Pharmacies pay $0.11311 to $0.28353 per GM for this product, depending on the NDC.
- How much is in the package I am getting? This page uses 1 g; your package may hold a different amount.
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for CHOLESTYRAMINE LIGHT POWDER labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Cholestyramine Light / Cholestyramine: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's GM. Joined on generic name.
- Why does this page start at 1 g?
- The FDA package descriptions of this product’s NDCs give different amounts (201.6 g, 210 g, 231 g, 239.4 g, 239.6 g). So the card starts at 1 GM; change it to match your prescription.